Saturday, Sep 26, 2020 | Last Update : 06:28 PM IST

186th Day Of Lockdown

Maharashtra130045899280634761 Andhra Pradesh6614585881695606 Tamil Nadu5693705138369148 Karnataka5572124503028417 Uttar Pradesh3785333136865450 Delhi2644502284365147 West Bengal2410592110204665 Odisha201059165432820 Telangana1816271501601080 Bihar175898161510881 Assam167374136712625 Kerala160935111327636 Gujarat1303911105923394 Rajasthan1247301042881412 Haryana1205781012731273 Madhya Pradesh117588932382152 Punjab107096840253134 Chhatisgarh9856566860777 Jharkhand7770964515661 Jammu and Kashmir69832495571105 Uttarakhand4533233642555 Goa3107125071386 Puducherry2548919781494 Tripura2412717464262 Himachal Pradesh136799526152 Chandigarh112128677145 Manipur9791760263 Arunachal Pradesh8649623014 Nagaland5768469311 Meghalaya5158334343 Sikkim2707199431 Mizoram178612880

Remdesivir

US hospitals turn down remdesivir, limit use to severely ill since July

The slowdown suggests that a shortage of the drug is over and threatens Gilead’s efforts to expand use of remdesivir

12 Sep 2020 1:10 PM

Dr. Reddy’s releases COVID drug Remdesivir under brand name Redyx

"Dr Reddy's Redyx is available in strength of 100 mg vial," it said

09 Sep 2020 12:21 PM

India's cheapest remdesivir version launched by Zydus Cadila at Rs 2,800 per vial

The drug will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients

13 Aug 2020 11:01 AM

Maharashtra FDA to buy remdesivir from Gujarat firm

State FDA minister Rajendra Shingne said the government plans to publish the price and availability of the drugs online for transparency

26 Jul 2020 3:55 PM

Jubilant Generics gets DCGI nod to manufacture COVID-19 drug Remdesivir

On June 21, Hetero and Cipla and on July 2 Mylan were given permission to manufacture and market the drug on the same conditions

21 Jul 2020 10:01 AM

ADVERTISEMENT

Seven held for selling Remdesivir injections at higher cost

The officials said that each vial of the injection was being sold at 30,000 instead of 4,500

20 Jul 2020 12:50 PM

Gilead starts testing inhaled version of remdesivir for COVID-19

Gilead also plans to start additional clinical trials to evaluate remdesivir when used in combination with anti-inflammatory medicines

09 Jul 2020 9:10 AM

Mylan Pharma to launch remdesivir in India at Rs 4,800 per 100 mg vial

The drug will be launched under the brand name Desrem in India and will be available to patients later this month

07 Jul 2020 1:48 PM

Remdesivir gets conditional EU clearance to be used in severe COVID-19 patients

The move comes just days after Gilead allocated nearly all of its supply of remdesivir for the next three months to the US

05 Jul 2020 1:54 PM

Cipla to price remdesivir version for COVID-19 under Rs 5,000

Gilead said on Monday it is targeting remdesivir supply for more than 2 million COVID-19 patients by the end of the year.

24 Jun 2020 9:16 AM

ADVERTISEMENT

Gilead Sciences to start trials of inhaled version of remdesivir

The FDA granted remdesivir an emergency use authorisation for the treatment of hospitalised patients with severe Covid-19

23 Jun 2020 3:47 PM

Dr Reddy's inks licensing pact with Gilead Sciences for Remdesivir

Gilead Sciences signed similar non-exclusive licensing agreements with Cipla, Hetero Labs, Jubilant Lifesciences, Mylan and Zydus Cadila

14 Jun 2020 9:59 AM

Health ministry okays remdesivir for moderate cases, HCQ for early course of COVID-19

It also okayed off-label application of tocilizumab, a drug that modifies the immune system or its functioning, and convalescent plasma

13 Jun 2020 11:35 PM

India's drug regulator grants Gilead Sciences marketing authorisation for remdesivir

The approval process for remdesivir was accelerated in view of emergency situation and unmet need for medicines in light of covid19 outbreak

03 Jun 2020 11:57 AM

Despite FDA warning, Trump says he is taking hydroxychloroquine

The Food and Drug Administration has issued a warning about its use

19 May 2020 10:15 AM

ADVERTISEMENT

Health groups want India to rescind Gilead drug patents

Advocacy groups want remdesivir to be distributed more fairly to coronavirus patients around the world.

15 May 2020 11:46 AM

Gilead ties up with 5 generic drugmakers in India, Pakistan for Covid19 drug supply

The licenses are royalty-free until the World Health Organization declares the end of the public health emergency regarding Covid-19

13 May 2020 8:44 AM

US allows use of remdesivir to help virus recovery

No drugs are currently FDA-approved for treating the coronavirus, and remdesivir will still need formal approval

02 May 2020 11:02 AM

US to roll back social distancing guidelines from tomorrow

Trump hopes to hold mass campaign rallies in the coming months, even though experts say there is little hope of having a vaccine by then

30 Apr 2020 10:29 AM

WHO Solidarity trial testing antiviral drug remdesivir, as it could stop coronavirus from replicating

In an observational study, 68 per cent or two out of three patients after treatment with the drug did not require ventilator support

14 Apr 2020 1:51 PM

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT